IKT 8-K 2026-07-14

Inhibikase Therapeutics, Inc. (IKT) 8-K dated 2026-07-14 — accession 0001193125-26-302580. This URL is the filing, not the IKT hub.

Inhibikase Therapeutics, Inc. (IKT) is a biotechnology company listed on US.

Inhibikase Therapeutics, Inc. filed a 8-K on 2026-07-14. Accession 0001193125-26-302580.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported IKT revenue for 2026-06-30 was $0. Net income was -$36.0M. IKT currently screens at market cap $215.2M.

Not investment advice. The IKT SEC hub lists recent forms. The stock page is the research view.